You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma
- 2. Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
- 3. Valo Therapeutics Acquires University of Helsinki's PeptiBAC Cancer and Infectious Disease Vaccination Technology
- 4. 3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq
- 5. Vidac Pharma Secures EUR 20m Capital Commitment From GEM
- 6. Data security startup Druva's valuation doubles to $2 bn on raising $147 mn
- 7. Clinical Catch-Up: April 12-16
- 8. TTXD appoints James Allison, Padmanee Sharma, and Mihai Netea to Scientific Advisory Board
- 9. Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell
- 10. A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection
Last updated at 7:10 GMT
Hot News Makers
Health/Pharma Companies
-
74022.11
-
38638.92
-
25698.22
-
15489.05
-
14848.99
-
12732.03
-
12375.41
-
11970.91
-
8070.57
-
7072.64
Last updated at 7:10 GMT
© Copyright 2021 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK